Healthcare resources and costs associated with nonvalvular atrial fibrillation in Spain: apixaban versus acenocoumarol

AIM: Healthcare resources usage and costs associated to nonvalvular atrial fibrillation (NVAF) were analyzed in Spain. METHODS: This is an observational and retrospective study on patients with NVAF who started their treatment with apixaban or acenocoumarol between 1 January 2015 and 31 December 201...

Descripción completa

Detalles Bibliográficos
Autores principales: Colet, Josep Comín, Mainar, Antoni Sicras, Salazar-Mendiguchía, Joel, del Campo Alonso, María Isabel, Echeto, Ainara, Larena, David Vilanova, Sánchez, Olga Delgado
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Becaris Publishing Ltd 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508311/
https://www.ncbi.nlm.nih.gov/pubmed/37489950
http://dx.doi.org/10.57264/cer-2023-0007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508311/
https://www.ncbi.nlm.nih.gov/pubmed/37489950
http://dx.doi.org/10.57264/cer-2023-0007

Ejemplares similares